We previously reported that perlecan, a heparan-sulfate proteoglycan (Hspg2), expressed in the synovium at the cartilage-synovial junction, is required for osteophyte formation in knee osteoarthritis. To examine the mechanism underlying this process, we examined the role of perlecan in the proliferation and differentiation of synovial mesenchymal cells (SMCs), using a recently established mouse synovial cell culture method. Primary SMCs isolated from Hspg2 -Tg (Hspg2 ;Col2a1-Hspg2 ) mice, in which the perlecan-knockout was rescued from perinatal lethality, lack perlecan. The chondrogenic-, osteogenic-, and adipogenic-potentials were examined in the Hspg2 -Tg SMCs compared to the control SMCs prepared from wild-type Hspg2 -Tg (Hspg2 ;Col2a1-Hspg2 ) littermates. In a culture condition permitting proliferation, both control and Hspg2 -Tg SMCs showed similar rates of proliferation and expression of cell surface markers. However, in micromass cultures, the cartilage matrix production and Sox9 and Col2a1 mRNA levels were significantly reduced in Hspg2 -Tg SMCs, compared with control SMCs. The reduced level of Sox9 mRNA was restored by the supplementation with exogenous perlecan protein. There was no difference in osteogenic differentiation between the control and Hspg2 -Tg SMCs, as measured by the levels of Runx2 and Col1a1 mRNA. The adipogenic induction and PPARγ mRNA levels were significantly reduced in Hspg2 -Tg SMCs compared to control SMCs. The reduction of PPARγ mRNA levels in Hspg2 -Tg SMCs was restored by supplementation of perlecan. Perlecan is required for the chondrogenic and adipogenic differentiation from SMCs via its regulation of the Sox9 and PPARγ gene expression, but not for osteogenic differentiation via Runx2. © 2016 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 35:837-846, 2017.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/jor.23318 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Dyssegmental dysplasia Rolland-Desbuquois type is caused by pathogenic variants in HSPG2 - a founder haplotype shared in five patients.
J Hum Genet
June 2024
Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Article Synopsis
- * Schwartz-Jampel syndrome (SJS), also caused by HSPG2 mutations, is related to DDSH, with 44 variants reported in SJS and 8 in DDSH.
- * Recent findings show that five DDRD patients had four pathogenic variants in HSPG2, highlighting a common genetic background, connecting SJS, DDRD, and DDSH as allelic disorders.
Evaluation of Human-Induced Pluripotent Stem Cells Derived from a Patient with Schwartz-Jampel Syndrome Revealed Distinct Hyperexcitability in the Skeletal Muscles.
Biomedicines
March 2023
Aging Biology in Health and Disease, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Article Synopsis
- - Schwartz-Jampel syndrome (SJS) is an autosomal recessive disorder caused by mutations in the gene that encodes perlecan, a key basement membrane protein, which leads to symptoms like myotonia—a muscle stiffness condition.
- - Diagnosing myotonia, especially in neonates and young children, is challenging since it's primarily based on physical examination, and there's limited understanding of how it develops in SJS.
- - Researchers created a cellular model of SJS using patient-derived stem cells, which showed heightened reactions to acetylcholine, helping to confirm the model's relevance for studying SJS and potentially aiding in the search for effective treatments.
Increased Risk of Aortic Dissection with Perlecan Deficiency.
Int J Mol Sci
December 2021
Research Institute for Diseases of Old Age, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Article Synopsis
- Perlecan (HSPG2) is a key protein in basement membranes that impacts the development of aortic tissue, but its specific role in maintaining the aortic wall is not well understood.
- Mice lacking perlecan (Perl KO) display torn elastic lamina and a higher incidence of aortic dissection (AD), revealing significant tissue structure changes, including immature elastic fibers and altered smooth muscle proteins.
- This study suggests that perlecan deficiency compromises the extracellular matrix in the aorta, proposing it as a new risk factor for aortic dissection due to its effects on aortic tissue integrity.
Perlecan Facilitates Neuronal Nitric Oxide Synthase Delocalization in Denervation-Induced Muscle Atrophy.
Cells
November 2020
Japanese Center for Research on Women in Sport, Juntendo University Graduate School of Health and Sports Science, Chiba 270-1695, Japan.
Perlecan is an extracellular matrix molecule anchored to the sarcolemma by a dystrophin-glycoprotein complex. Perlecan-deficient mice are tolerant to muscle atrophy, suggesting that perlecan negatively regulates mechanical stress-dependent skeletal muscle mass. Delocalization of neuronal nitric oxide synthase (nNOS) from the sarcolemma to the cytosol triggers protein degradation, thereby initiating skeletal muscle atrophy.
View Article and Find Full Text PDFPerlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier.
J Cell Biol
October 2019
Molecular Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD
Ischemic stroke causes blood-brain barrier (BBB) breakdown due to significant damage to the integrity of BBB components. Recent studies have highlighted the importance of pericytes in the repair process of BBB functions triggered by PDGFRβ up-regulation. Here, we show that perlecan, a major heparan sulfate proteoglycan of basement membranes, aids in BBB maintenance and repair through pericyte interactions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!